Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00759096 · ClinicalTrials.gov registry record · NA

Clinical Assessment of Visual Function With the Acrysof ReSTOR Multifocal IOL

A NA study of Visual Acuity, sponsored by Alcon Research.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT00759096 is a NA study of Visual Acuity that has completed, run by Alcon Research. The registered enrollment target is 30 participants, below the 139-participant average among 20 other Visual Acuity trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00759096, a NA study of Visual Acuity, has completed, sponsored by Alcon Research.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess uniocular and binocular unaided distance, intermediate, and near VA; contrast sensitivity, accommodation amplitude, stereopsis, glare testing, ocular aberrations and the clinical satisfaction assessment after bilateral implant of the Restor IOL.

Conditions Studied

Interventions

  • DEVICE RESTOR IOL Model SA60D3

Study Locations (1)

Texas

  • Alcon Call Center - Fort Worth

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2007-05
Est. Completion 2008-07
Phase NA

Sponsor

Alcon Research

275 total trials

What the Registry Record Tells You About NCT00759096

The ClinicalTrials.gov registry entry for NCT00759096 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 139-participant average among 20 other Visual Acuity trials with a reported enrollment target (78% lower). The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Visual Acuity appearing as the primary indexed condition, and to 1 intervention - of which RESTOR IOL Model SA60D3 is the first listed.

NCT00759096 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT00759096 about?

NCT00759096 is a clinical study titled "Clinical Assessment of Visual Function With the Acrysof ReSTOR Multifocal IOL". The purpose of this study is to assess uniocular and binocular unaided distance, intermediate, and near VA; contrast sensitivity, accommodation amplitude, stereopsis, glare testing, ocular aberrations and the clinical satisfaction assessment after bilateral implant of the Restor IOL.

What is the current status of trial NCT00759096?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2007-05. Estimated completion is 2008-07.

What conditions does trial NCT00759096 study?

This clinical trial studies the following conditions: Visual Acuity.

What interventions are being tested in trial NCT00759096?

The interventions under investigation include: RESTOR IOL Model SA60D3 (DEVICE).

Who is sponsoring clinical trial NCT00759096?

This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00759096 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Visual Acuity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.